Frontlight ResearchEarly access
Sickle cell disease trials in Ireland
1 of 1 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in IrelandA Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
- Where
- Dublin 8
- Age
- 12 years and over
- People
- 159 worldwide
- Run by
- Agios Pharmaceuticals, Inc.
See details and how to joinNCT07656415 · EU 2026-526778-18-00